ES2113549T3 - Metodo para inhibir la replicacion de vih empleando il-4. - Google Patents

Metodo para inhibir la replicacion de vih empleando il-4.

Info

Publication number
ES2113549T3
ES2113549T3 ES93920000T ES93920000T ES2113549T3 ES 2113549 T3 ES2113549 T3 ES 2113549T3 ES 93920000 T ES93920000 T ES 93920000T ES 93920000 T ES93920000 T ES 93920000T ES 2113549 T3 ES2113549 T3 ES 2113549T3
Authority
ES
Spain
Prior art keywords
pct
hiv replication
inhibiting hiv
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920000T
Other languages
English (en)
Inventor
Jerome Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2113549T3 publication Critical patent/ES2113549T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION PROPORCIONA UN METODO PARA TRATAR UNA INFECCION HIV EN UN PACIENTE, QUE COMPRENDE ADMINISTRAR AL PACIENTE INFECTADO UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA IL - 4.
ES93920000T 1992-08-19 1993-08-17 Metodo para inhibir la replicacion de vih empleando il-4. Expired - Lifetime ES2113549T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93213492A 1992-08-19 1992-08-19

Publications (1)

Publication Number Publication Date
ES2113549T3 true ES2113549T3 (es) 1998-05-01

Family

ID=25461831

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920000T Expired - Lifetime ES2113549T3 (es) 1992-08-19 1993-08-17 Metodo para inhibir la replicacion de vih empleando il-4.

Country Status (22)

Country Link
US (1) US5700461A (es)
EP (1) EP0656785B1 (es)
JP (1) JP2711182B2 (es)
KR (1) KR950702838A (es)
CN (1) CN1086437A (es)
AT (1) ATE163860T1 (es)
AU (1) AU683427B2 (es)
CA (1) CA2142862C (es)
CZ (1) CZ38095A3 (es)
DE (1) DE69317428T2 (es)
ES (1) ES2113549T3 (es)
FI (1) FI950696A0 (es)
HU (1) HUT72709A (es)
IL (1) IL106717A0 (es)
MX (1) MX9305016A (es)
NO (1) NO950599L (es)
NZ (1) NZ255735A (es)
PL (1) PL307508A1 (es)
SK (1) SK21295A3 (es)
TW (1) TW291439B (es)
WO (1) WO1994004179A1 (es)
ZA (1) ZA936018B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2329474C (en) 1995-11-02 2002-02-26 Schering Corporation Continuous low-dose cytokine infusion therapy
US20040132161A1 (en) * 1998-04-20 2004-07-08 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US20050124645A1 (en) * 1998-04-20 2005-06-09 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US20030232738A1 (en) * 1998-04-20 2003-12-18 National Jewish Medical And Research Center Method and composition for increasing CD4+ T lymphocyte immune responsiveness
AU4716299A (en) * 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US6734192B1 (en) 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
JPH02485A (ja) * 1987-08-03 1990-01-05 Yuu Honshiyo 新規なヒトインターロイキン４、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
ES2082201T3 (es) * 1990-03-21 1996-03-16 Schering Corp Uso de il-4 para mejorar la respuesta inmune a las pruebas de antigenos infecciosos.
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
EP0490006B1 (en) * 1990-12-13 1994-06-22 Schering-Plough Pharmaceutical compositions for the treatment of B-cell malignancies

Also Published As

Publication number Publication date
JP2711182B2 (ja) 1998-02-10
PL307508A1 (en) 1995-05-29
CA2142862A1 (en) 1994-03-03
IL106717A0 (en) 1993-12-08
KR950702838A (ko) 1995-08-23
WO1994004179A1 (en) 1994-03-03
SK21295A3 (en) 1997-01-08
AU683427B2 (en) 1997-11-13
HUT72709A (en) 1996-05-28
MX9305016A (es) 1994-02-28
NZ255735A (en) 1997-06-24
EP0656785A1 (en) 1995-06-14
NO950599D0 (no) 1995-02-17
DE69317428T2 (de) 1998-07-02
NO950599L (no) 1995-02-17
DE69317428D1 (de) 1998-04-16
CZ38095A3 (en) 1995-12-13
AU5007593A (en) 1994-03-15
US5700461A (en) 1997-12-23
ZA936018B (en) 1994-06-13
ATE163860T1 (de) 1998-03-15
CA2142862C (en) 2000-05-30
EP0656785B1 (en) 1998-03-11
CN1086437A (zh) 1994-05-11
FI950696A (fi) 1995-02-16
TW291439B (es) 1996-11-21
HU9500487D0 (en) 1995-04-28
JPH07506116A (ja) 1995-07-06
FI950696A0 (fi) 1995-02-16

Similar Documents

Publication Publication Date Title
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ES2150022T3 (es) Aerosol farmaceutico que contiene al menos un azucar.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
NO954215D0 (no) Transdermal medikament-fremstilling
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
AU4923093A (en) Inhibitors of metazoan parasite proteases
BR9509975A (pt) Formulação farmacêutica
ES2113549T3 (es) Metodo para inhibir la replicacion de vih empleando il-4.
TW261532B (es)
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
AU1081695A (en) The use of an ester of inositoltrisphosphate for the preparing of medicaments
EE03385B1 (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
DK0651648T3 (da) Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom
SE9301831D0 (sv) Pharmaceutical compositions
GB9507883D0 (en) Compounds
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
DK0678022T3 (da) Anvendelse af riluzol ved fremstilling af lægemidler, som er anvendelige til behandling af stråleskader

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 656785

Country of ref document: ES